Superior Effectiveness and Estimated Public Health Impact of Cell- Versus Egg-Based Influenza Vaccines in Children and Adults During the US 2023–2024 Season
Our analysis showed superior effectiveness of QIVc over QIVe in preventing test-confirmed influenza among persons aged 6 months-64 years, and provided the first demonstration of superiority in pediatric populations from 6 months of age. A Graphical Abstract is availible for this article.
Authors
- Mendel Haag (ORCID: https://orcid.org/0000-0001-7895-7556)
- Alicia Stein (ORCID: https://orcid.org/0009-0009-8383-1662)
- Christopher D. Pack (ORCID: https://orcid.org/0000-0002-6325-7837)
- Ian McGovern (ORCID: https://orcid.org/0000-0002-0282-7728)
- Alex Dean
- Sheena G. Sullivan (ORCID: https://orcid.org/0000-0002-0856-0294)
- Sarah Wall (ORCID: https://orcid.org/0000-0002-9572-0953)
- Kimberly W. McDermott
- Anusorn Thanataveerat
Institutions
- Seqirus (United States) (US)
- Monash University (AU)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1007/s40121-025-01230-2
- Citations
- 1
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35